Tejara Capital’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Buy |
326,395
+146,879
| +82% | +$803K | 0.83% | 38 |
|
|
2025
Q1 | $1.13M | Buy |
179,516
+25,777
| +17% | +$162K | 0.44% | 53 |
|
|
2024
Q4 | $633K | Sell |
153,739
-87,874
| -36% | -$362K | 0.41% | 43 |
|
|
2024
Q3 | $807K | Sell |
241,613
-164,375
| -40% | -$549K | 0.38% | 47 |
|
|
2024
Q2 | $1.21M | Buy |
405,988
+368,507
| +983% | +$1.1M | 0.44% | 49 |
|
|
2024
Q1 | $129K | Sell |
37,481
-1,231,519
| -97% | -$4.25M | 0.05% | 70 |
|
|
2023
Q4 | $1.7M | Buy |
1,269,000
+1,088,773
| +604% | +$1.46M | 0.71% | 37 |
|
|
2023
Q3 | $393K | Hold |
180,227
| – | – | 0.22% | 53 |
|
|
2023
Q2 | $431K | Sell |
180,227
-9,991
| -5% | -$23.9K | 0.21% | 60 |
|
|
2023
Q1 | $352K | Buy |
190,218
+40,260
| +27% | +$74.5K | 0.18% | 66 |
|
|
2022
Q4 | $289K | Buy |
+149,958
| New | +$289K | 0.17% | 79 |
|